Tower Research Capital LLC (Trc) Y M Abs Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,390 shares of YMAB stock, worth $60,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,390

Previous 6,902 21.91%

Holding current value

$60,044

Previous $83,000 15.66%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.95 - $15.39 $15,044 - $23,269	-1,512 Reduced 21.91%	5,390 $70,000
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.25 $40,785 - $60,651	3,516 Added 103.84%	6,902 $83,000
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $21,681 - $61,677	-3,300 Reduced 49.36%	3,386 $55,000
Q4 2023 Feb 13, 2024	BUY	$4.88 - $7.42 $25,302 - $38,472	5,185 Added 345.44%	6,686 $45,000
Q3 2023 Nov 14, 2023	BUY	$4.86 - $7.23 $427 - $636	88 Added 6.23%	1,501 $8,000
Q2 2023 Aug 14, 2023	SELL	$5.68 - $10.34 $25,480 - $46,385	-4,486 Reduced 76.05%	1,413 $9,000
Q1 2023 May 09, 2023	BUY	$2.83 - $5.11 $15,064 - $27,200	5,323 Added 924.13%	5,899 $30,000
Q4 2022 Feb 10, 2023	SELL	$3.0 - $15.17 $3,024 - $15,291	-1,008 Reduced 63.64%	576 $3,000
Q3 2022 Nov 10, 2022	SELL	$13.96 - $19.67 $36,296 - $51,142	-2,600 Reduced 62.14%	1,584 $23,000
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $10,718 - $19,729	1,304 Added 45.28%	4,184 $63,000
Q1 2022 May 12, 2022	SELL	$6.55 - $17.42 $1,932 - $5,138	-295 Reduced 9.29%	2,880 $34,000
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $14,455 - $27,316	932 Added 41.55%	3,175 $52,000
Q3 2021 Nov 15, 2021	BUY	$27.47 - $37.31 $12,306 - $16,714	448 Added 24.96%	2,243 $64,000
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $57,364 - $84,840	-2,254 Reduced 55.67%	1,795 $61,000
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $36,450 - $64,950	1,250 Added 44.66%	4,049 $122,000
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $69,359 - $99,404	1,832 Added 189.45%	2,799 $138,000
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $60,283 - $74,851	-1,716 Reduced 63.96%	967 $37,000
Q2 2020 Aug 13, 2020	BUY	$23.66 - $49.53 $63,479 - $132,888	2,683 New	2,683 $116,000
Q1 2020 May 15, 2020	SELL	$14.39 - $35.8 $7,943 - $19,761	-552 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$23.81 - $33.78 $13,143 - $18,646	552 New	552 $17,000
Q3 2019 Nov 05, 2019	SELL	$21.57 - $31.37 $15,961 - $23,213	-740 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$19.51 - $28.31 $10,242 - $14,862	525 Added 244.19%	740 $17,000
Q1 2019 May 14, 2019	SELL	$18.21 - $26.21 $2,585 - $3,721	-142 Reduced 39.78%	215 $6,000
Q4 2018 Feb 14, 2019	BUY	$15.41 - $28.92 $5,501 - $10,324	357 New	357 $7,000

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Y M Abs Therapeutics, Inc. Transaction History